SPOTLIGHT: Big Pharma's biotech shift hurts chemists

2007 may be remembered as the year Big Pharma moved away from chemical-based drugs and fully embraced the biologics revolution. AstraZeneca, Sanofi, and (most notably) Pfizer--among many others--have announced initiatives that involve boosting investment in biotech drugs. But with chemical-based drugs out of vogue, there's a group that's been forced to go job-hunting: chemists. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.